Suchergebnisse - "Clinical Trial, Phase I"

PubPharm (25.987)

1

Bioequivalence of 240 mg Apalutamide Tablets and Preparation in Aqueous Food Vehicles for Alternative Administration

enthalten in: Clinical pharmacology in drug development | 2024

von Yu, A. | Van Uffel, M. | Jiao, J. | +3

2

A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours

enthalten in: British journal of cancer | 2024

von Burris, H. | Berlin, J. | Arkenau, T. | +9

3

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001) : results from arm 1 of a non-randomised, single-centre, phase 1/2 study

enthalten in: The Lancet. Oncology | 2024

von Musher, B. | Rowinsky, E. | Smaglo, B. | +17

4

SAFE-ROCK : A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants

enthalten in: CNS drugs | 2024

von Wolff, A. | Peine, J. | Höfler, J. | +3

5

Safety, pharmacokinetics, and pharmacodynamics of anti-IL-4Rα antibody SHR-1819 in healthy subjects : A randomized, controlled phase I study

enthalten in: Clinical and translational science | 2024

von Li, N. | Shakib, S. | Qian, W. | +5

6

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PF-06817024 in Healthy Participants, Participants with Chronic Rhinosinusitis with Nasal Polyps, and Participants with Atopic Dermatitis : A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study

enthalten in: Journal of clinical pharmacology | 2024

von Danto, S. | Tsamandouras, N. | Reddy, P. | +6

7

A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors : phase 1 trial interim results

enthalten in: Nature medicine | 2024

von Rappaport, A. | Kyi, C. | Lane, M. | +35

8

Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer : results from the dose expansion groups of an open-label, phase 1b study

enthalten in: The Lancet. Oncology | 2024

von Layman, R. | Han, H. | Rugo, H. | +9

9

Safety and Pharmacokinetics of Quizartinib Combination Therapy With Standard Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia : Results from Two Phase 1 Trials in Japan and China

enthalten in: Clinical pharmacology in drug development | 2024

von Qi, J. | Choi, I. | Ota, S. | +9

10

Clinical pharmacology and tolerability of REC-994, a redox-cycling nitroxide compound, in randomized phase 1 dose-finding studies

enthalten in: Pharmacology research & perspectives | 2024

von Alfa, R. | Considine, T. | Virani, S. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[2599]